This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Université Pierre Et Marie Curie (Paris 6). Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Cathia Soulie: Innovator in Viral Infection Treatment
Introduction
Cathia Soulie is a notable inventor based in Paris, France. She has made significant contributions to the field of virology, particularly in the treatment of viral infections. Her innovative work has led to the development of a patent that addresses critical health challenges.
Latest Patents
Cathia Soulie holds a patent for "Nucleoside analogues for the treatment of a viral infection, and method for evaluating the sensitivity to said treatment." This invention describes the use of nucleoside analogs specifically for treating viral infections, including HIV. The patent also outlines compositions that include these analogs and a method for assessing the sensitivity to the treatment.
Career Highlights
Throughout her career, Cathia has been associated with prestigious institutions such as Université Pierre et Marie Curie (Paris 6) and Université Paris Descartes. Her work in these universities has contributed to advancing research in viral infections and treatment methodologies.
Collaborations
Cathia has collaborated with esteemed colleagues, including Matthieu Sollogoub and Anne-Geneviève Marcelin. These partnerships have fostered a collaborative environment that enhances research and innovation in her field.
Conclusion
Cathia Soulie's contributions to the treatment of viral infections through her patented innovations highlight her role as a leading inventor in the scientific community. Her work continues to impact the field of virology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile